A New Sensitive, Time-Saving Assay for Preclinical Research of Cancer, Fibrosis, and Inflammatory Diseases STATE COLLEGE, PENNSYLVANIA, UNITED STATES, June 4, 2024 ...
Agonist dose-response of Human HNF4a. Inverse-Agonist dose-response of Human HNF4a. A New Sensitive, Time-Saving Assay for Preclinical Research of Metabolic Regulation and Disease Pathogenesis STATE ...
Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback